JP2025500123A5 - - Google Patents
Info
- Publication number
- JP2025500123A5 JP2025500123A5 JP2024529338A JP2024529338A JP2025500123A5 JP 2025500123 A5 JP2025500123 A5 JP 2025500123A5 JP 2024529338 A JP2024529338 A JP 2024529338A JP 2024529338 A JP2024529338 A JP 2024529338A JP 2025500123 A5 JP2025500123 A5 JP 2025500123A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292783P | 2021-12-22 | 2021-12-22 | |
| US63/292,783 | 2021-12-22 | ||
| PCT/EP2022/087342 WO2023118366A1 (en) | 2021-12-22 | 2022-12-21 | Gap junction modulators and their use for the treatment of age-related macular degeneration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025500123A JP2025500123A (ja) | 2025-01-09 |
| JP2025500123A5 true JP2025500123A5 (https=) | 2025-12-25 |
| JPWO2023118366A5 JPWO2023118366A5 (https=) | 2025-12-25 |
Family
ID=84981302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529338A Pending JP2025500123A (ja) | 2021-12-22 | 2022-12-21 | ギャップ結合モジュレーターおよび加齢黄斑変性の処置のためのその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250018002A1 (https=) |
| EP (1) | EP4452260B1 (https=) |
| JP (1) | JP2025500123A (https=) |
| CN (1) | CN118450892A (https=) |
| CA (1) | CA3240515A1 (https=) |
| DK (1) | DK4452260T3 (https=) |
| FI (1) | FI4452260T3 (https=) |
| IL (1) | IL313729A (https=) |
| WO (1) | WO2023118366A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202310195D0 (en) * | 2023-07-03 | 2023-08-16 | Hastings Nataly | Method for mitigating symptoms of neurological condition and a system therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6259296A (ja) | 1985-09-10 | 1987-03-14 | Green Cross Corp:The | ペプタイド誘導体 |
| IL157447A0 (en) | 2001-02-22 | 2004-03-28 | Zealand Pharma As Zealand Phar | New medical uses of intercellular communication facilitating compounds |
| UA96283C2 (uk) | 2005-12-23 | 2011-10-25 | Зіланд Фарма А/С | Модифіковані міметики лізину |
| PL2468724T3 (pl) | 2006-12-21 | 2016-05-31 | Zealand Pharma As | Synteza związków pirolidynowych |
| JP6989864B2 (ja) * | 2017-05-05 | 2022-02-03 | ジーランド ファーマ，アー／エス | ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用 |
-
2022
- 2022-12-21 CN CN202280084727.5A patent/CN118450892A/zh active Pending
- 2022-12-21 IL IL313729A patent/IL313729A/en unknown
- 2022-12-21 US US18/708,367 patent/US20250018002A1/en active Pending
- 2022-12-21 CA CA3240515A patent/CA3240515A1/en active Pending
- 2022-12-21 WO PCT/EP2022/087342 patent/WO2023118366A1/en not_active Ceased
- 2022-12-21 DK DK22843707.5T patent/DK4452260T3/da active
- 2022-12-21 FI FIEP22843707.5T patent/FI4452260T3/fi active
- 2022-12-21 EP EP22843707.5A patent/EP4452260B1/en active Active
- 2022-12-21 JP JP2024529338A patent/JP2025500123A/ja active Pending